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Abstract 
Rho GTPases control cell morphogenesis and thus fundamental processes in all eukaryotes. 
They are regulated by 145 RhoGEF and RhoGAP multi-domain proteins in humans. How the 
Rho signaling system is organized to generate localized responses in cells and prevent their 
spreading is not understood. Here, we systematically characterized the substrate specificities, 
localization and interactome of the RhoGEFs/RhoGAPs and revealed their critical role in 
contextualizing and spatially delimiting Rho signaling. They localize to multiple compartments 
providing positional information, are extensively interconnected to jointly coordinate their 
signaling networks and are widely autoinhibited to remain sensitive to local activation. 
RhoGAPs exhibit lower substrate specificity than RhoGEFs and may contribute to preserving 
Rho activity gradients. Our approach led us to uncover a multi-RhoGEF complex downstream of 
G-protein-coupled receptors controlling a Cdc42/RhoA crosstalk. The spatial organization of 
Rho signaling thus differs from other small GTPases and expands the repertoire of mechanisms 
governing localized signaling activity.  
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Rho GTPases coordinate changes in cytoskeletal architecture to regulate cell shape. They drive 
fundamental aspects of cell behavior in all eukaryotes, including motility, cytokinesis and tissue 
morphogenesis(1, 2). Defects in Rho signaling have been widely found in cancer metastasis and 
other serious diseases(3). Rho proteins typically cycle between an inactive GDP-bound and an 
active GTP-bound form(4). Upon activation, they bind effector proteins to elicit cytoskeletal 
remodeling. Their activity cycle is initiated by guanine nucleotide exchange factors 
(RhoGEFs)(5, 6) and terminated by GTPase activating proteins (RhoGAPs)(7). In addition, 
guanine nucleotide dissociation inhibitors (RhoGDIs) sequester the GTPases in the cytosol to 
render them inactive(8). With 145 members, the RhoGEF/RhoGAP multi-domain proteins by 
far outnumber the 12 classical Rho GTPase switch proteins they regulate, allowing for complex 
control of Rho signaling activity and specificity (Fig. S1).  
Rho signaling responses in cells are highly localized. A critical aspect of Rho biology is therefore 
its spatiotemporal control(9). Rho activities have been observed in distinct subcellular 
zones(10–13), with several GTPases operating simultaneously. Cell morphogenesis thus 
involves the concerted action of multiple Rho family members and their regulators, which 
together form complex local networks(14, 15). However, our knowledge how the Rho signaling 
system is orchestrated to give rise to such spatially confined cell responses is limited and stems 
from studies on individual Rho regulators, while a systems-level view is lacking.  
Here, we undertook a comprehensive characterization of the RhoGEFs and RhoGAPs, including 
their substrate specificities, subcellular localization and interactomes. Our study places the 
regulators in functional context and enabled us to uncover emergent spatial organization 
principles that contribute to our understanding how Rho activity zones are dynamically 
maintained in cells. 
 
RhoGAPs exhibit lower substrate selectivity than RhoGEFs in a family-wide activity screen 
We generated an expression library comprising 141 mammalian full-length RhoGEF/RhoGAP 
cDNAs, almost all of which represent the longest isoform known to exist (Fig. S1; Table S1).  
As a first step, we systematically characterized the substrate specificities of the regulators to 
link them to their downstream pathways. An extensive literature survey and curation of 
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claimed specificities revealed an incomplete data landscape with a high degree of conflict 
between reports (Table S2, Supplementary Text), highlighting the need for a standardized 
comprehensive analysis. We therefore developed a screening-compatible automated live-cell 
imaging assay using the latest generation of FRET-based biosensors for the canonical GTPases 
RhoA, Rac1 and Cdc42(16–18) (Fig. S2C-H). This approach enables the analysis of full-length 
regulators in their native cellular environment. We found catalytic activities for 45 out of 75 
RhoGEFs and for 48 out of 63 RhoGAPs tested. In addition, the dual GEF/GAP proteins ABR and 
BCR both exhibited GAP activity (Fig. 1, Fig. S2A,B, Table S2). The active regulators included 
proteins whose substrate specificity was exclusive to one target (35 RhoGEFs, 31 RhoGAPs) but 
also many that regulated multiple Rho GTPases (10 RhoGEFs, 19 RhoGAPs). Our results thus 
not only reveal extensive promiscuity among the regulators, but also that in the GDP/GTP 
reaction cycle the inactivating RhoGAPs are less selective than the activating RhoGEFs (p-
value=0.02)(Table S2). Promiscuity has been predominantly reported in the co-regulation of 
Cdc42 and Rac1, presumably because they control related cytoskeletal processes such as the 
formation of actin-rich protrusions at the leading edge (19, 20). However, we found a similar 
number of regulators that control RhoA together with Cdc42 and/or Rac1 (18 and 17 vs. 16), 
and thus GTPase combinations that elicit more diverse downstream responses, including RhoA-
dependent regulation of actomyosin contractility. While we see high overall agreement of 
identified substrate specificities with existing data (70%, Table S2), we describe 10 novel 
activities. PLEKHG4B, for instance, is a strong exclusive Cdc42 GEF (see also Fig. 5) and SYDE2 a 
Rac1-specific GAP. The screen also revealed discrepancies with literature. The previously 
proposed representative Cdc42-specific GAPs ARHGAP1, ARHGAP17 or ARHGAP31 showed 
either no activity towards this GTPase in our assay or rather inactivated Rac1 more efficiently. 
In fact, none of the GAPs tested exhibited exclusive substrate specificity for Cdc42, although 21 
GAPs promiscuously regulated Cdc42. By contrast, we found exclusive Cdc42 activity for a total 
of 12 GEFs.  
Autoinhibition is a common feature of RhoGEFs and RhoGAPs 
Some RhoGEFs and RhoGAPs displayed minimal or no activity in our screen. A requirement for 
release from autoinhibition via mechanisms such as phosphorylation, protein or lipid 
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interactions may account for the observed inactivity(21). To study whether autoinhibition is a 
general mechanism in controlling the Rho regulators we included shorter forms of 9 RhoGEFs 
and 10 RhoGAPs, which lack potential regulatory elements present in the longest isoforms. 13 
of the shorter proteins indeed exhibited a higher catalytic efficiency than their longer 
counterparts (Fig. 2). ARHGAP9 normally only exhibits catalytic activity towards Rac1 as its 
longest isoform. Surprisingly, isoform 3, lacking an N-terminal SH3 domain, also inactivated 
Cdc42, suggesting that autoregulatory features might also affect the substrate selectivity of 
Rho regulators. Overall, our data shows that RhoGEFs and RhoGAPs are widely subject to 
autoinhibition. 
RhoGEFs and RhoGAPs display diverse spatial distribution in cells  
To understand how RhoGEFs and RhoGAPs provide spatial information to Rho signaling, we 
mapped the subcellular distribution of all 141 regulators in our library. We first used confocal 
live-cell microscopy to screen YFP fusion proteins in MDCK epithelial cell. This analysis revealed 
that over half of RhoGEFs and RhoGAPs (76/141) inherently localize to one or more distinct 
structures at steady-state, collectively decorating virtually all cellular compartments (Fig. 3A, 
Fig. S3, Table S3). For two proteins, ARHGAP9 and MCF2L2, we observed dependence of 
localization on the position of the fluorescent protein tag (Fig. S3). Interestingly, ARHGAP9-YFP 
localized to mitochondria while YFP-ARHGAP9 was enriched at cell junctions, perhaps because 
the N-terminal YFP fusion disrupted a mitochondrial targeting signal predicted for ARHGAP9 
residues 1-14 (PredSL tool(22)). Indeed, ARHGAP9-YFP isoform 3, lacking residues 1-181, did 
not localize to mitochondria. We identified eight other cases in which different isoforms 
exhibited distinct localization patterns (Fig. S3). 
Focal adhesions are major sites of Rho GTPase regulation  
To enhance the ability to resolve RhoGEF/RhoGAP localization to focal adhesions, a key site of 
cytoskeletal dynamics, we used total internal reflection fluorescence (TIRF) microscopy in COS-
7 cells. This led to the identification of an unexpected one fourth (37) of all RhoGEFs and 
RhoGAPs that clearly associated with these structures, as determined by colocalization with 
the adhesion marker Paxillin. Efforts to define the components of integrin adhesions have 
already revealed a prevalence of Rho signaling network proteins(23, 24). 9 RhoGEFs/RhoGAPs 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/354316doi: bioRxiv preprint first posted online Jun. 24, 2018; 
6  
were previously proposed to be an integral part of the adhesome (adhesome.org), of which we 
confirmed six. For 24 proteins identified in our screen no evidence for focal adhesion 
localization existed in literature (Table S3), among them well-studied regulators such as SOS, 
TRIO, CHN2 and KALRN (Fig. 3B, Fig. S4). Our data thus indicates that intricately tuned Rho 
signaling is more crucial in the control of cell-matrix adhesion than previously assumed.  
Notably, six regulators exhibited a distinct microlocalization with a pericentric enrichment 
juxtapositioned to focal adhesions and a fluorescence intensity minimum in the center (Fig. 
S5). We also found that RhoGEFs and RhoGAPs with activity towards Rac1 were 
overrepresented at focal adhesions compared to RhoA and Cdc42 (Fig. S6, Tables S2, S3). 
Prevalence of actin-associated RhoGEFs and RhoGAPs  
Next, we focused on identifying regulators associating with actin. We treated cells with 
Cytochalasin D, an agent that disrupts the actin network and induces the appearance of 
phalloidin-reactive filamentous foci (25). By scoring transiently expressed RhoGEFs and 
RhoGAPs for their colocalization with these foci, we identified 34 actin-associated proteins, 
including 23 regulators that have previously not been reported to bind actin, such as DOCK1, 
ITSN2 and ARHGAP5 (Fig. 3C and Fig. S7). This finding emphasizes the importance of close 
proximity of Rho regulators to actin to locally sense and control cytoskeletal dynamics. 
RhoGEFs and RhoGAPs with activity towards Cdc42 were overrepresented for association with 
actin relative to RhoA and Rac1 (Fig. S6).  
 
Overall, we found 70% (99/141) of the overexpressed RhoGEF/RhoGAP proteins enriched at 
distinct subcellular compartments (Fig. 3D, Table S3). The vast majority of regulators thereby 
localize to structures previously shown to harbor Rho signaling. Notably, additional ‘non-
canonical’ locations, comprising the Golgi, mitochondria, lysosomes, endomembranes and the 
endoplasmic reticulum, were only decorated by RhoGAPs. We thus did not find evidence for 
Rho activation at these structures. Compared to a control set of proteins from the Cell Atlas 
study (26), significantly more proteins in our screen localized to focal adhesions, actin and the 
plasma membrane (p-values < 2.2e-16, < 2.2e-16, 4.154e-07 and odds ratios=30.2, 14.5 and 2.9 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/354316doi: bioRxiv preprint first posted online Jun. 24, 2018; 
7  
respectively). Compared to a study that assessed localization in a similar manner as our 
study(27), the RhoGEFs/RhoGAPs in our set were significantly enriched in terms of discrete 
localization (i.e. not cytoplasm or nucleus; p-value=4.083e-09, odds ratio=3.0). For 27 (19%) of 
the regulators in our collection, there were no previous reports describing their localization, 
and 28 (20%) and 53 (37.5%) were not annotated in the Cell Atlas and Uniprot databases, 
respectively. For 38 proteins (27%) the localizations we found were different from those 
reported (Table S3). Together, our data provides a cellular heat-map of Rho regulation and 
establishes the critical role of the RhoGEFs/RhoGAPs in conveying spatial context to Rho 
signaling.  
Using high-content microscopy(28), we found only a limited relationship between the 
substrate specificities and overexpression phenotypes of the RhoGEFs/RhoGAPs 
(Supplementary Text). Their expression thus results in a continuum of cell morphologies that 
contrasts the clear-cut phenotypes observed upon global expression of activated forms of the 
Rho GTPases(29), reflecting the promiscuity and differential subcellular distribution of the 
RhoGEFs and RhoGAPs. 
Interactome analysis reveals that many RhoGEFs/RhoGAPs associate in complexes 
Next, we used affinity purification coupled to mass spectrometry to obtain a comprehensive 
network of 1292 interactions (silver set; 1082 novel) among 863 unique proteins (Fig. 4A, Table 
S4). Our dataset explores a so far largely uncharted part of the human interactome and 
connects Rho GTPases to several signaling pathways(30) and functional complexes involved in 
linking the actin cytoskeleton to critical cell functions (Fig. 4A, Fig. S8). Notably, in addition to 
20 interactions between RhoGEFs or RhoGAPs and Rho effector proteins and 24 interactions 
with small GTPases, our network includes 66 unique interactions between RhoGEFs/RhoGAPs 
themselves, indicating a previously unrecognized extensive crosstalk among the Rho regulators 
(Fig. 4B, enrichment p-value for all <<0.001; Fig. S9). Both homo- and heterotypic interactions 
occurred, with fewer complexes between RhoGAPs (24 GEF/GAP, 28 GEF/GEF, 11 GAP/GAP 
and 3 GEF-ABR or GEF-BCR). Connections include complexes that localize to the same cellular 
compartment, such as FARP2-VAV1 on focal adhesions or ARHGAP28-SYDE1 on actin filaments, 
where they may act in concert to fine-tune Rho responses (Fig. 4B).  
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Protein complexes controlling RhoGEF/RhoGAP localization 
We found that the interactomes of focal adhesion-associated RhoGEFs/RhoGAPs are enriched 
in components of the adhesome(24) (Table S4, p-value=2.5e-08) and asked whether we could 
identify interactors that are responsible for their local recruitment. We selected ARHGAP39, a 
neuronal RacGAP controlling synaptic plasticity(31), and confirmed its interaction with PEAK1, 
a kinase implicated in cancer progression. PEAK1 also localized to focal complexes, as 
previously reported(32). The interaction critically involves a WW domain of ARHGAP39: when 
this domain is disrupted by a Y81A point mutation, it not only fails to associate with PEAK1 but 
is also no longer recruited to focal adhesions(Fig. S10). Likewise, the interactome of actin-
localized regulators is enriched in actin-binding proteins (p-value=1e-13), whose function may 
be to similarly recruit these RhoGEFs/RhoGAPs (Table S4, Supplementary Text). C-DOCK 
RhoGEF subfamily regulators (DOCK6-8) were highly interconnected with the four members of 
the LRCH protein family (Fig. S11, Table S4). Indeed, we found a striking relocalization of the 
three RhoGEFs from the cytosol to the sites of LRCH expression: peripheral actin filaments and 
the endoplasmic reticulum. Given that RhoGEFs/RhoGAPs and their interactors are significantly 
enriched for PDZ, SH2, WW and SH3 domains (p-values <<0.01), which are common in scaffold 
or adaptor proteins, such recruitment likely affects the cellular distribution also of other Rho 
regulators.   
A multi-RhoGEF complex downstream of GPCR signaling mediates Rho GTPase crosstalk 
To further study the interplay between Rho regulators, we functionally characterized a multi-
RhoGEF complex identified in our proteomics analysis: the interaction between the yet 
undescribed RhoGEF PLEKHG4B and ARHGEF11 and ARHGEF12, two well-studied activators of 
RhoA signaling downstream of G protein-coupled receptors (GPCR) that have been shown to 
be essential for chemokine signaling-driven tumor cell invasion(33, 34) (Fig. 4B, Fig. 5A, Fig. 
S12A). ARHGEF11/12 are engaged at the membrane upon GPCR stimulation when activated 
heterotrimeric Gɑ12 and Gɑ13 subunits bind to the RGS (regulator of G protein signaling) 
domains of the GEFs(35). PLEKHG4B is one of the eight members of the Pleckstrin homology 
domain containing family G (PLEKHG) proteins. The N-termini of the three proteins are critical 
to this interaction (Fig. 5B). While ARHGEF11 and ARHGEF12 are RhoA-specific, PLEKHG4B 
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selectively activated Cdc42 (Fig. 5C) and thus draws an additional Rho GTPase substrate into 
this multi-GEF assembly. We observed that PLEKHG4B is another RhoGEF that is subject to 
autoinhibition, as the truncation of the N-terminus of PLEKHG4B increased its Cdc42 GEF 
activity compared to the full-length form (Fig. 5E, Fig. S12B). An increase in the Cdc42 GEF 
activity of full-length PLEKHG4B appeared when we added either N-terminal fragments of 
ARHGEF11 or ARHGEF12 or catalytically inactive mutants (Fig. 5C-E). This suggests that binding 
to its partner GEFs releases the autoinhibition of PLEKHG4B. Conversely, coexpressing an N-
terminal fragment of PLEKHG4B or its GEF-inactive mutant strongly decreased the catalytic 
activities of ARHGEF11 and ARHGEF12 towards RhoA (Fig. 5D,F). The three proteins thus 
mutually control one another’s GEF activities. In the context of the GPCR signaling pathway, 
both ARHGEF11 and ARHGEF12 selectively associated with constitutively active Gɑ13QL, as 
expected. Addition of PLEKHG4B, however, inhibited this interaction (Fig. 5G, upper panels). 
Fittingly, while the expression of Gɑ13QL robustly activated downstream Rho signaling through 
engagement of the endogenous RGS domain-containing RhoGEFs, this response was inhibited 
by the dominant negative ARHGEF11 N-terminus that competes with the endogenous GEFs for 
Gɑ13 binding(36). Importantly, the N-terminus of PLEKHG4B, also capable of binding to 
ARHGEF11/12, caused an equally strong inhibition of Gɑ13 signaling.  
To our knowledge, this is the first description of a multi-Rho regulator assembly, consisting of 
exchange factors with different GTPase specificities. In complex, ARHGEF11 and ARHGEF12 
enhance the Cdc42 GEF activity of PLEKHG4B. In return, PLEKHG4B inhibits ARHGEF11/12-
mediated RhoA activation in two ways: directly by reducing their catalytic activity, and 
indirectly by perturbing their engagement with Gɑ12/13. We thus provide a proof of concept 
for a novel mechanism of cross-talk among Rho GTPases in a pathway implicated in cancer 
metastasis, that was previously thought to only activate RhoA(37) (Fig. 5H).  
 
Discussion 
Rho GTPases orchestrate complex morphodynamic cell behaviors. A fundamental question is 
how the underlying highly localized processes are spatially maintained while the components 
of the Rho signaling system are subject to entropic leakage. Recent studies have challenged the 
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perception of Rho signaling as a static, linear and ‘GTPase-centric’ process, in which a 
membrane-bound GTPase is sequentially regulated by a GEF and a GAP to control one specific 
cytoskeletal structure(12, 13, 38, 39). Here, we provide the first systems-level study of 
RhoGEF/RhoGAP function that establishes the framework for a dynamic ‘regulator-centric’ 
concept. A critical function of the RhoGEFs and RhoGAPs is to contextualize and spatially 
delimit the Rho signaling networks. They do so by providing positional cues based on the 
placement of the enzymes on dedicated supramolecular structures and the assembly of 
additional signaling proteins. Our data establishes focal adhesions and actin filaments as 
additional major sites of Rho signaling regulation. 
We found that many regulators associate to collaborative networks, such as the 
PLEKHG4B/ARHGEF11/ARHGEF12 complex characterized here. This cooperativity of the 
RhoGEFs/RhoGAPs, together with their promiscuity towards their substrates, increases their 
combinatorial possibilities to engage multiple Rho family members simultaneously, and to fine-
tune their activities. Most regulators are autoinhibited, presumably due to the back-folding of 
adjacent regions onto the catalytic domains, thereby preventing access to substrates(40–42). 
This suggests that the RhoGEFs/RhoGAPs are poised to respond to context-specific upstream 
stimuli and feedback regulation, a mechanism that can further spatially confine the activity of 
the regulators to micrometer-size zones while localizing on supramolecular structures. 
Diffusion spreads the activated GTPases from their source and thereby the local 
morphogenetic signals. This is balanced by an efficient turnover of the GDP/GTP cycle, 
mediated by the action of RhoGAPs in the vicinity of the activated GTPases. RhoGAPs are more 
promiscuous than RhoGEFs, a finding that is in agreement with previous biochemical studies 
on selected regulators(43, 44). They are also less interconnected in homotypic GAP/GAP 
complexes and have significantly fewer domains than RhoGEFs (p-value=5e-04), and are thus 
potentially more autonomous from regulation. Moreover, only RhoGAPs localize to ‘non-
canonical’ structures that are not reported to host Rho signaling. These properties may 
contribute to a housekeeping function of the RhoGAPs, allowing them to efficiently reset the 
basal state of the GDP/GTP cycle and thus to prevent signals from leaking to the cell volume. 
This is reminiscent of other fundamental reaction cycles driven by the activities of opposing 
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enzymes. Inactivating protein phosphatases, for example, also tend to display lower sequence 
selectivity than their kinase counterparts(45). RhoGDIs finally ensure the re-cycling of Rho 
GTPases through the confined activity zones.  
The lack of Cdc42-GAP specificity is surprising. Cdc42 activity often peaks at early stages of 
cellular morphogenesis, for instance during cell polarization, protrusion or adhesion and may 
have a unique initiating role in these processes. A failsafe termination of the underlying 
signaling programs may require the rigorous simultaneous inactivation of the entire cascade of 
Rho GTPases involved, including Rac1 and RhoA. 
The mechanisms governing local Rho signaling are fundamentally different from those in place 
in the Ras GTPase system, with only about 16 GEFs/GAPs(46). Here, spatial organization does 
not require the contribution of opposing regulators but instead arises from cycles of lipid 
anchoring and membrane release of the Ras proteins(47–49). The organization principles 
presented in this study thus add to the emerging landscape of mechanisms controlling 
localized activities of small GTPases.  
This integrated study provides a basis by which the complexity of spatio-temporal control of 
Rho signaling can be further dissected and rules by which cells regulate context-specific 
functions can be explored. 
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Figure 1. Family-wide RhoGEF and RhoGAP activity screens 
(A) HEK293T cells were transfected with the mCherry-labeled RhoGEF cDNA library and the FRET sensors RhoA-2G, Rac1-2G, and Cdc42-2G together with RhoGDI. (B) RhoGDI shRNA-depleted HEK293T cells were transfected with the mCherry-labeled RhoGAP cDNA library and indicated FRET sensors. Values show ĐhaŶges iŶ FRET ratio ;ΔRͿ Đoŵpared to ĐoŶtrol 
Ŷorŵalized to the ŵaǆiŵal oďserǀed FRET ratio ĐhaŶge ;ΔRMAX). Mean ± SD (n=3) is shown throughout. Dashed lines indicate activity thresholds. Significance of values above (A) or 
ďeloǁ ;BͿ the threshold ǁas ĐalĐulated ďǇ uŶpaired StudeŶt’s t-test versus control and Benjamini-Hochberg procedure, significant values are marked with an asterisk (*). For regulators with multiple activities, only those above 20% of the main activity were considered. Venn diagrams and lists of active regulators are given sorted by substrate GTPases: RhoA (green), Rac1 (blue), and Cdc42 (red).   
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Figure 2. Autoinhibition is a common feature of RhoGEFs and RhoGAPs  
Semiquantitative comparison of catalytic activities of full-length longest isoforms versus shorter isoforms or truncations of randomly selected 9 RhoGEFs (A) and 10 RhoGAPs (B). Experiments were performed as described in Figure 1 and Figure S2. Graphs on the left 
represeŶt ĐhaŶges iŶ FRET ratio ;ΔRͿ Ŷorŵalized to RhoGEF or RhoGAP expression levels as determined by mCherry intensity. Graphs on the right show the FRET ratios normalized to control. Dashed lines indicate activity thresholds as in Figure 1. Values show mean ± SD (n=3; 
Ŷ=2 for ARHGEF40 aŶd DNMBPͿ. SigŶifiĐaŶĐe leǀels ǁere ĐalĐulated ďy uŶpaired StudeŶt’s t-tests as indicated: ***p<0.001, **p<0.01, *p<0.05, n.s.=not significant. Right panels: domain representations of the used constructs, as in Figure S1.  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/354316doi: bioRxiv preprint first posted online Jun. 24, 2018; 
PIK3R1
ARHGAP22
ARAP2
focal adhesions
ARHGAP9-YFPmitochondriaARHGAP26endopl. reticulum
ARHGAP24
ARHGEF2
ARHGAP42
cytoskeleton
OCRL
ITSN1
ARHGAP1vesicles nucleusARHGAP12
FARP1
plasma membraneA
B
Figure 3
D
PLE
KHG
3
ARH
GEF
11
ARH
GEF
11ab
m
ARHGAP36lysosomes
C
Tub
ulin
YFP phalloidin YFP / phalloidin
SH3
BP1
ARAP2, ARHGAP9, ARHGAP12, ARHGAP22, ARHGAP23, ARHGAP31, ARHGAP35, ARHGAP39CHN2, DLC1, OCRL, PIK3R1, PIK3R2, SRGAP1, SRGAP3, STARD8, STARD13, SYDE1, SYDE2
18 RhoGEFs ARHGEF6, ARHGEF7, ARHGEF19, ARHGEF39, DOCK1, DOCK3, DOCK5, ECT2L, FARP2ITSN1, ITSN2, KALRN, PLEKHG1, SOS1, SOS2, TRIO, VAV1, VAV3 
19 RhoGAPs
focal adhesion associated
16 RhoGEFs
17 RhoGAPs
actin associated
ARAP2, ARAP3, ARHGAP5, ARHGAP9, ARHGAP11A, ARHGAP24, 
MYO9A, MYO9B, OPHN1, SH3BP1, SRGAP1, SYDE1
ARHGEF11, ARHGEF15, ARHGEF17, ARHGEF18, ARHGEF26, 
PLEKHG2, PLEKHG3, PLEKHG4B, PLEKHG6 
BCR
DOCK1, FGD1, FGD2, FGD4, FGD6, ITSN2, PLEKHG1, 
ARHGAP28, ARHGAP29, ARHGAP33, ARHGAP35, ARHGAP42,
1 RhoGEF/GAP
FGD5
ARHGAP11A
ARHGAP19
ARHGEF3
ARH
GAP
5
YFP phalloidin YFP / phalloidinCHN1-α1endomembranes ARHGAP21Golgi
0.0
2.0
4.0
norm
. inte
nsity
0.0
1.0
2.0
3.0
norm
. inte
nsity
TRIO
0.0
2.0
4.0
norm
. inte
nsity
0.0
1.0
2.0
3.0
norm
. inte
nsity
SOS
1
0.0
2.0
4.0
norm
. inte
nsity
0.0
1.0
2.0
3.0
norm
. inte
nsity
KAL
RN
longitudinalintensity plot transverseintensity plotmergePaxillinRhoGEF
NGEF DOCK8
PREX2
ARHGEF28
DOCK6
PLEKHG4
ARHGAP44
TAGAP
ARHGAP18
PREX1
ARHGAP4
ARHGEF1
ARHGAP10
FAM13A
ARAP1
ARHGEF10
DOCK4
VAV2
ALS2
MCF2L
PLEKHG7
ARHGAP36 ARHGAP1
INPP5B
FGD5
GMIP
FARP1
DEPDC1B
ARHGAP20
TIAM1
DOCK9
HMHA1
DOCK2
AKAP13
ARHGEF9
ARHGEF40
ABRDEPDC1
ARHGAP8
MCF2
FAM13B
ARHGAP15
ARHGAP40
DOCK7
STARD13 ARHGEF18
ARAP2
ARHGAP24ARHGEF7 PIK3R2
SYDE1VAV1
DLC1 ECT2LCHN2
ARHGEF6ITSN1
STARD8
VAV3
ARHGEF11
OCRL
ITSN2
ARHGAP33
ARHGAP5
ARAP3
FGD1
FGD2
ARHGAP42
PLEKHG6
OPHN1
ARHGEF26
SH3BP1
ARHGEF19
ARHGEF15
KALRN
SRGAP3
FARP2
ARHGAP22 DOCK1
DOCK3SYDE2
ARHGAP35DOCK5 PLEKHG3PLEKHG1PIK3R1 TRIO
BCR
FGD6
PLEKHG2
MYO9B
FGD4
ARHGAP28
MYO9A
PLEKHG4B
ARHGAP11ARASGRF2
TIAM2ECT2 NET1 ARHGAP31
ARHGAP19
ARHGAP26RALBP1 FGD3CHN1
ARHGEF3 RACGAP1
ARHGEF2
ARHGEF28ARHGEF10L ARHGAP6
ARHGAP27
ARHGEF12
ARHGAP25ARHGAP30
ARHGAP11B
ARHGEF4
DOCK11
RASGRF1
ARHGAP39
DOCK10
ARHGEF39
ARHGEF25SPATA13
cytosol
actin
plasma membrane
focal adhesions
filaments
vesicles
nucleus
SOS1SOS2
ARHGEF5
tubulin
ARHGEF16
ARHGAP12
ARHGAP23
ARHGAP29
ARHGAP17
ARHGAP21
ARHGAP9
PLEKHG5
SRGAP1
SRGAP2MCF2L2
DNMBP
ARHGEF17
ARHGAP32
focal adhesions
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/354316doi: bioRxiv preprint first posted online Jun. 24, 2018; 
Figure 3. RhoGEFs and RhoGAPs display diverse spatial distribution in cells 
Selection of images from confocal live-cell microscopy screen of YFP-tagged RhoGEF and RhoGAP subcellular localization (A), TIRF microscopy focal adhesion localization screen (B), and Cytochalasin D-treated actin colocacalization screen (C). (B) Image insets show higher magnifications of the boxed areas. Right panels: normalized fluorescence intensity profiles of longitudinal and transverse sections through focal adhesions, indicated by white lines in the merged images. (C) abm = actin binding mutant. Scale bars: (A) 10 µm, (B) white scale bars: 20 µm, black scale bars: 5 µm, (C) 10 µm. (D) Summary of the distribution of RhoGEF and RhoGAP proteins over different subcellular compartments.  
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Figure 4. The RhoGEF/RhoGAP interactome is highly interconnected and includes components of multiple cellular processes 
(A) RhoGEF/RhoGAP interactome network. As examples of subnetworks of the RhoGEF/RhoGAP interactome, interactions with complexes involved in cell polarity, junctions, membrane trafficking, growth factor receptor signaling and actin cytoskeleton organization are shown. (B) Bait-bait interactome. Our network is enriched (p-value <<0.001) in bait-bait interactions among RhoGEFs and RhoGAPs. Shown are all 66 interactions, with nodes color-coded by their subcellular localization (see also Figure 3).   
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Figure 5. A multi-RhoGEF complex downstream of GPCR  
(A) Schematic of the three human RhoGEFs and truncations used. (B) PLEKHG4B, ARHGEF11 and ARHGEF12 interact via their N-termini. Immunoprecipitations of indicated YFP-PLEKHG4B constructs with indicated FLAG-ARHGEF11 or FLAG-ARHGEF12 constructs from lysates of transfected HEK293T cells. (C) ARHGEF11 and ARHGEF12 are RhoA-specific GEFs, whereas PLEKHG4B activates Cdc42. FRET assay as described in Figure 1A and Figure S2. GEF-dead mutants: ARHGEF11-Y885A ARHGEF12-Y940A, PLEKHG4B-Y943A. (D) Sequence alignment of human ARHGEF11, ARHGEF12 and PLEKHG4B revealing the conserved tyrosine in the DH domain critical for catalysis(50). (E) Autoinhibition of PLEKHG4B and its release by ARHGEF11 and ARHGEF12 binding. Left panel: PLEKHG4B-stimulated SRE-luciferase reporter activation assay. Right panel: Cdc42-2G FRET ratios of HEK293T cells transfected with RhoGDI, mCherry-tagged PLEKHG4B and the indicated miRFP-tagged ARHGEF11 and ARHGEF12 mutants. (F) ARHGEF11 and ARHGEF12 are inhibited by PLEKHG4B. Upper panel: ARHGEF11/12-stimulated SRE-luciferase reporter activation assay. Anti-FLAG Western Blot shows the expression of the transfected constructs. Lower panel: RhoA-2G FRET ratios of HEK293T cells transfected with RhoGDI, mCherry-ARHGEF11/12 and the indicated miRFP-
tagged PLEKHGϰB ŵutaŶts. ;GͿ PLEKHGϰB iŶhiďits Gαϭϯ-mediated ARHGEF11/12 recruitment and downstream RhoA activation. Upper left panel: Immunoprecipitations of YFP-fusions of the three GEFs with wild type (WT) or constitutively active FLAG-Gαϭϯ ;QLͿ from lysates of transfected HEK293T cells. Upper right panel: Immunoprecipitations of YFP-tagged ARHGEF11/12 with indicated FLAG-tagged proteins from lysates of transfected HEK293T cells. Lower left panel: GαϭϯQL-stimulated SRE-luciferase reporter activation assay. Anti-FLAG Western Blot shows the expression of transfected constructs. (H) Model of PLEKHG4B interaction with ARHGEF11 and ARHGEF12 and their mutual regulation of 
GαϭϮ/ϭϯ-mediated GPCR signaling. All bar graphs show mean ± SD (n=3: C, E left, F, and G; n=4: E right). SigŶifiĐaŶĐe was ĐalĐulated ďy uŶpaired StudeŶt’s t-test (C, E right, F, and G) versus control+RhoGDI (C), versus PLEKHG4B (E right) or as indicated by lines. Significance was determined using One-way ANOVA, followed ďy Tukey’s ŵultiple ĐoŵparisoŶs ;E left). Significance was ranked as * p<0.05, ** p<0.01, *** p<0.001. 
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